Login / Signup

Discovery of Molecular Glue Degraders via Isogenic Morphological Profiling.

Amanda NgFabian OffenspergerJose A CisnerosNatalie S ScholesMonika MalikLudovica VillantiAndrea RukavinaEvandro FerradaJ Thomas HannichAnna KorenStefan KubicekGiulio Superti-FurgaGeorg E Winter
Published in: ACS chemical biology (2023)
Molecular glue degraders (MGDs) are small molecules that degrade proteins of interest via the ubiquitin-proteasome system. While MGDs were historically discovered serendipitously, approaches for MGD discovery now include cell-viability-based drug screens or data mining of public transcriptomics and drug response datasets. These approaches, however, have target spaces restricted to the essential proteins. Here we develop a high-throughput workflow for MGD discovery that also reaches the nonessential proteome. This workflow begins with the rapid synthesis of a compound library by sulfur(VI) fluoride exchange chemistry coupled to a morphological profiling assay in isogenic cell lines that vary in levels of the E3 ligase CRBN. By comparing the morphological changes induced by compound treatment across the isogenic cell lines, we were able to identify FL2-14 as a CRBN-dependent MGD targeting the nonessential protein GSPT2. We envision that this workflow would contribute to the discovery and characterization of MGDs that target a wider range of proteins.
Keyphrases
  • high throughput
  • single cell
  • small molecule
  • rna seq
  • electronic health record
  • healthcare
  • adverse drug
  • protein protein
  • mental health
  • emergency department
  • drug delivery
  • dna methylation
  • artificial intelligence